Skip to main content

Table 3 Agreement between actual prescribing of ICS/LABA for 59 COPD patients (FEV 1 /FVC <0.7) with no concomitant diagnosis of asthma in 2009/10 and the prescribing recommended based on the 2007–2010 GOLD guidelines

From: Predictors of ICS/LABA prescribing in COPD patients: a study from general practice

  ICS/LABA recommended (FEV1% predicted <50 and previous exacerbation)  
ICS/LABA Yes No  
Prescribed 2009/10    
 Yes 9 14 23
 No 2 34 36
  11 48 59
  Kappa = 0.37 (SE 0.12)